Loading stock data…
NVST
$26.33+0.39 (+1.50%)
Market ClosedLast close May 1
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Envista Holdings Corporation in the Healthcare sector is trading at $26.33. The stock is currently 13% below its 52-week high of $30.42, remaining 15.1% above its 200-day moving average. Technical signals show neutral RSI of 43 and bearish MACD signal, explaining why NVST maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 43) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$26.33
Potential Downside
81%
Whystock Fair Value$5.00
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus13 analysts
Buy
Mean target$28.69+9.0%
Range$21.00 – $35.00
Fundamentals
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Eq...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.41B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
96.57
Beta
Defensive asset. Lower volatility than the S&P 500.
0.98
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
1.73%
Volume
Today's trading volume
1.67M
Recent News
Here’s What Analysts Are Saying About Envista (NVST)
Envista Holdings Corporation (NYSE:NVST) is one of the 10 Best Medical Stocks to Buy Under $30. On April 24, Morgan Stanley raised its price target on Envista Holdings Corporation (NYSE:NVST) from $19 to $21 while maintaining an Equal Weight rating on the stock. The research firm noted that its US dental survey indicates weaker practice […]
Envista (NYSE:NVST): Strongest Q4 Results from the Dental Equipment & Technology Group
Looking back on dental equipment & technology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Envista (NYSE:NVST) and its peers.
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy costs.
Abbott (ABT) Beats Q1 Earnings and Revenue Estimates
Abbott (ABT) delivered earnings and revenue surprises of +0.59% and +1.31%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls
Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls